Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine.

City attorneys allege major Pharmacy Benefit Managers (PBMs) and insulin manufacturers are conspiring to artificially inflate ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

The treatment has been around for over a century but insulin has still ... has dropped the list of the next 15 drugs to be negotiated by Medicare. Eli Lilly has revised its revenue forecast ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

The reaction from Lilly's competitors arrived quickly. Novo Nordisk lowered the list price on various insulin products, including pre-filled insulin pens and vials. The company suggested that this ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...